About Us Locations Disclaimer

Dr. R. deGoma

Home
Prevention 2012
Who Needs Prevention
Benefits of Prevention
Risk Assessment
Advanced Lipid Therapy
Specialized Center
Performance Data
Employer Mandate
Employee Prevention
Patient Mentoring
Coronary Calcium Score
Women & Heart Disease
Adopting Healthy Habits

 

Click here for NJ Preventive Cardiology practice brochure

 

Mentoring Program

For Physicians:

Practical Tips for Clinicians

For Communities:

Heart2Heart Talk

For Employers and Employees: You and Health Reform

     



 

http://www.cdc.gov/Features/millionhearts/


Heart disease constitutes 17% of the overall national health spending. The country can no longer afford to spend this large sum of money that it does not have, on heart disease that is now considered largely preventable.

The above slide demonstrates why cardiovascular disease consumes a tremendous amount of healthcare dollars - its natural course is one of silent progression and recurring cardiovascular events - heart attacks and strokes. The treatments of very advanced disease - hospitalizations, stents, heart bypass, are very expensive. For over a decade now, optimal medical therapy using inexpensive generic medications, has been available to prevent or delay most of these events.

The above slide calculates how many lives could be saved if just 60% of high risk (those with 10 Year Framingham Risk Score of over 20%) adult Americans received optimal medical therapy for their risk factors. It also compares the magnitude of mortality reduction with primary and secondary prevention (optimal medical therapy) compared to more expensive stents and heart bypass.

 

Practical Tips and Clinical Tools for Primary Care Physicians...

Being developed.

Emil M. deGoma, MD, FACC

Medical Director,

UPenn Preventive Cardiovascular  Program

Health Premium Discount

Lower your risk for heart attack and stroke using evidence-based therapies and become eligible for a substantial premium discount by 2014.
Health Reform 2010
Prevention and Wellness Summary Provisions
Relay Health
Contact Office for Non-Urgent Matters

 

We Support Million Hearts Initiative

 

497,470 Preventable CHD Deaths Annually with Evidence-based Medical Therapy

 

JAMA: 38% of Nonacute Stents Called into Question

 

Optimal Medical Therapy Still Underused in CHD

 

Legacy Effects of Statin Therapy - Reduction in All-Cause Mortality

 

SG2 Expert Talks About Resetting Priorities in Cardiology

 

AHA: Get With The Guidelines - Not Much Improvement

 

AIM-HIGH Trial - Take Home Message

 

    
www.deGomaMD.com
Copyright 2001-2011     Preventing Most Heart Attacks and Strokes since 2001     eMedical Consulting     All rights reserved